All Articles

With $4.5M donated last year, MAC's iconic lipstick program has evolved from an AIDS crusade into a global force for racial, gender, and environmental justice.

Aardvark Therapeutics is expanding its Phase 3 trial for a novel Prader-Willi Syndrome drug to include children as young as seven, targeting a key unmet need.

Lithuanian manufacturer Eurodita's 'no minimum order' private-label plan could reshape Europe's construction market for independent dealers.

As Milestone Pharma launches its novel, self-administered heart drug CARDAMYST, it hires a legal expert to navigate the high-stakes commercial rollout.

After a stock plunge, Yext offers to buy back shares at a premium, signaling deep undervaluation and creating a critical choice for its investors.

The tech firm launches a dedicated healthcare vertical, using AI to simplify complex EHRs and give clinicians more time for patient care.

The Toronto-based e-commerce firm posts impressive growth, turning a prior year loss into a $1.5M profit by mastering grocery and golf markets.

DFR Gold secures $1.2M in insider loans, pushing total debt to $4.5M. The funds aim to fast-track its Burkina Faso gold project, but is it a vote of confidence or a sign of financial strain?

With a fresh $28M in funding, Natilus is set to commercialize its hyper-efficient blended-wing aircraft, threatening the Boeing-Airbus duopoly.

After posting strong preliminary Q4 results, Harvard Bioscience unveils a new strategy to lead the booming organoid and translational science market.

The financial services firm posted lower delinquency and loss rates for January, but is it a sign of a healthier consumer or savvy internal strategy?

Ahead of its first Climate Week, Mumbai's food innovators and activists gather to debate a sustainable future, proving the fight for the planet begins on our plates.

With a new U.S. listing, Rio Silver aims to leverage American capital to fast-track high-grade silver projects amid a booming precious metals market.

A Canadian family-owned food manufacturer expands with a new facility and pasta line, capitalizing on the booming demand for ready-to-eat ingredients.

The drive-thru coffee giant is moving into your kitchen, taking on Starbucks and Nestlé with its new retail line. But can its 'Dutch Luv' succeed on shelves?

Amid major restructuring and a strategic asset sale, Standard BioTools' upcoming annual results will reveal its progress toward profitability in a tough market.

A new low-risk rental program from Alfa Laval lets ethanol producers boost valuable corn oil yields without the massive upfront cost of new equipment.

A new AI-native law firm uses tech to find dangerous products decades early, promising faster justice. But is it a revolution or a regulatory risk?

With a fresh $118M in funding, Garner Health's AI platform aims to cut healthcare costs by guiding millions of patients to top-rated doctors.

A massive new IKEA study finds nearly 1 in 5 people eat on the sofa. Discover how screens, space, and modern life are transforming our most human ritual.